LCA Continues to Advocate for Increased Federal Research Funding

LCA continues to advocate that lung cancer research funding not be subject to budget cuts and sequestration. We joined Susan G. Komen for the Cure Advocacy Alliance, Vietnam Veterans of America, Leukemia and Lymphoma Society and many other leading public health organizations in a letter to Senate and House leadership that advocated for the continued investment in the invaluable lung cancer research that is supported by the CDMRPs. (Congressionally Directed Medical Research Programs) within the Department of Defense. In 2009, LCA established the pipeline and to date has secured $70M.